Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2015-12-18 Capital/Financing Update
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes a preliminary prospectus, details about the offering, underwriting, risk factors, and other disclosures typical of an initial public offering or other securities registration. This is not an annual report, earnings release, or any other financial report type but a capital markets filing related to fundraising and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is a full registration statement, not just an announcement or a certification, so it is not RPA or RNS.
2015-12-18 English
10-Q
Interim / Quarterly Report 9M 2015
2015-11-12 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 12, 2015, by Collegium Pharmaceutical, Inc. It specifically states in Item 2.02 that the company issued a press release announcing its financial results for the quarterly period ended September 30, 2015. The document includes the press release as Exhibit 99.1 but does not contain the full financial statements or detailed financial analysis itself. The text indicates that the press release is being furnished, not filed, and the 8-K serves as a current report to announce the earnings release. Given the nature of the document as an initial announcement of quarterly financial results and the presence of a press release, the appropriate classification is Earnings Release (ER). The document length is under 5,000 characters and is primarily an announcement rather than a full report, supporting the ER classification rather than an Interim Report (IR).
2015-11-12 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 registration statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock incentive plans and employee stock purchase plans. It includes detailed information about the plans, the securities to be registered, and legal and indemnification provisions. It is not a financial report, earnings release, or management discussion, nor is it an announcement of a report. It is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is a full filing, not a brief announcement or certification.
2015-11-02 English
SCHEDULE 13G
Major Shareholding Notification
2015-09-22 English
PRIMARY DOCUMENT
Director's Dealing
2015-09-14 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.